CompletedNot Applicable

Clinical Impact Analysis of PA-100 AST in a Spanish GP Setting

Spain199 participantsStarted 2024-07-01

Plain-language summary

Assessment of workflow implications of the PA-100 AST System. Using well-defined data collection protocols, the study comprises the following: * Collection of clean-catch midstream urine samples * Measurement of specimens on the PA-100 AST System o Antibiotics tested: Amoxicillin/clavulanic acid (AMC), Ciprofloxacin (CIP), Trimethoprim (TRI), Fosfomycin (FOS) and Nitrofurantoin (NIT) * Treatment of patients according to the results of the tests on the PA-100 AST System * Collection of data about patient treatment and antibiotic prescription when the PA-100 AST System is not used (study baseline) * Collection of patient related information * Collection of workflow-related information, including doctors and nurses at the test location * Evaluation of changes in the prescription behaviour when using the PA-100 AST System, compared to current practice at the Test Location

Who can participate

Age range18 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: Patients were recruited according to the following criteria: non-pregnant female, \>18 years old, presenting with acute UTI symptoms that had been present for \< 7 days (symptoms according to the current guidelines \[EAU\]), with no antibiotic treatment within the previous 7 days, positive urine dipstick for leukocyte esterase (LEU) and/or nitrites (NIT) and who provided a clean-catch mid-stream urine sample. Exclusion Criteria: Withdraw of consent

What they're measuring

Frequency of antibiotic prescription

Timeframe: At initial GP visit

Trial details

NCT IDNCT07189429

SponsorSysmex Europe GmbH

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2025-06-30

View on ClinicalTrials.gov More UTI - Urinary Tract Infection trials